tipifarnib has been researched along with rottlerin in 1 studies
| Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (rottlerin) | Trials (rottlerin) | Recent Studies (post-2010) (rottlerin) |
|---|---|---|---|---|---|
| 309 | 92 | 94 | 556 | 1 | 202 |
| Protein | Taxonomy | tipifarnib (IC50) | rottlerin (IC50) |
|---|---|---|---|
| Eukaryotic elongation factor 2 kinase | Homo sapiens (human) | 5.3 | |
| B2 bradykinin receptor | Cavia porcellus (domestic guinea pig) | 1.2 | |
| Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens (human) | 8 | |
| Beta-lactamase | Escherichia coli K-12 | 1.5 | |
| Malate dehydrogenase | Thermus thermophilus | 0.7 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 1.2 | |
| MAP kinase-activated protein kinase 2 | Homo sapiens (human) | 5.4 | |
| Protein kinase C delta type | Homo sapiens (human) | 3 | |
| MAP kinase-activated protein kinase 5 | Homo sapiens (human) | 1.9 | |
| WD repeat-containing protein 48 | Homo sapiens (human) | 8 | |
| RuvB-like 1 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwon, M; Lee, DW; Lee, HN; Lee, W | 1 |
1 other study(ies) available for tipifarnib and rottlerin
| Article | Year |
|---|---|
Dual inhibition of FOXM1 and its compensatory signaling pathway decreased the survival of ovarian cancer cells.
Topics: Acetophenones; Benzopyrans; Cell Line, Tumor; Cell Survival; Female; Forkhead Box Protein M1; GTP Phosphohydrolases; Humans; Membrane Proteins; Ovarian Neoplasms; Pyridines; Quinazolines; Quinolones; Signal Transduction; Thiophenes | 2021 |